日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Neoadjuvant anthracycline-based (5-FEC) or anthracycline-free (docetaxel/carboplatin) chemotherapy plus trastuzumab and pertuzmab in HER2 + BC patients according to their TOP2A: a multicentre, open-label, non-randomized phase II trial

根据 TOP2A 方案,对 HER2 阳性乳腺癌患者进行新辅助蒽环类药物化疗(5-FEC 方案)或不含蒽环类药物的化疗(多西他赛/卡铂方案)联合曲妥珠单抗和帕妥珠单抗治疗:一项多中心、开放标签、非随机 II 期试验

Ginzac, Angeline; Molnar, Ioana; Durando, Xavier; Motte Rouge, Thibault De La; Petit, Thierry; D'hondt, Véronique; Campone, Mario; Bonichon-Lamichhane, Nathalie; Venat Bouvet, Laurence; Levy, Christelle; Augereau, Paule; Pistilli, Barbara; Arsene, Olivier; Jouannaud, Christelle; Nguyen, Suzanne; Cayre, Anne; Tixier, Lucie; Mahier Ait Oukhatar, Céline; Nabholtz, Jean-Marc; Penault-Llorca, Frédérique; Mouret-Reynier, Marie-Ange

Long term activity of vemurafenib in cancers with BRAF mutations: the ACSE basket study for advanced cancers other than BRAF(V600)-mutated melanoma

维莫非尼在BRAF突变癌症中的长期疗效:ACSE针对除BRAF(V600)突变型黑色素瘤以外的晚期癌症的篮式研究

Blay, J Y; Cropet, C; Mansard, S; Loriot, Y; De La Fouchardière, C; Haroche, J; Topart, D; Tougeron, D; You, B; Italiano, A; Le Brun-Ly, V; Ferrero, J M; Penel, N; Fabbro, M; Troussard, X; Malka, D; Ray-Coquard, I; Leboulleux, S; Fléchon, A; Maubec, E; Charles, J; Dalle, S; Taieb, S; Garcia, G C T E; Mandache, A M; Colignon, N; Gavrel, M; Nowak, F; Hoog Labouret, N; Mahier Aït Oukhatar, C; Gomez-Roca, C

Persistent response to vemurafenib in metastatic ameloblastoma with BRAF mutation: a case report

BRAF突变转移性成釉细胞瘤患者对维莫非尼持续反应:病例报告

Broudic-Guibert, Morgane; Blay, Jean-Yves; Vazquez, Léa; Evrard, Alexandre; Karanian, Marie; Taïeb, Sophie; Hoog-Labouret, Natalie; Oukhatar, Céline Mahier Ait; Boustany-Grenier, Rania; Arnaud, Antoine

Combined abiraterone acetate plus prednisone, salvage prostate bed radiotherapy and LH-RH agonists (CARLHA-GEP12) in biochemically-relapsing prostate cancer patients following prostatectomy: A phase I study of the GETUG/GEP

联合使用醋酸阿比特龙和泼尼松、挽救性前列腺床放疗和 LH-RH 激动剂 (CARLHA-GEP12) 治疗前列腺切除术后生化复发前列腺癌患者:GETUG/GEP 的 I 期研究

Stéphane Supiot, Loic Campion, Pascal Pommier, Mélanie Dore, Clément Palpacuer, Séverine Racadot, Emmanuel Rio, Gérard A Milano, Céline Mahier-Ait Oukhatar, Christian Carrie

Prognostic impact of blood and urinary angiogenic factor levels at diagnosis and during treatment in patients with osteosarcoma: a prospective study

骨肉瘤患者诊断和治疗期间血液和尿液血管生成因子水平对预后的影响:一项前瞻性研究

Marie-Dominique Tabone, Laurence Brugières, Sophie Piperno-Neumann, Marie-Ange Selva, Perrine Marec-Bérard, Hélène Pacquement, Cyril Lervat, Nadège Corradini, Jean-Claude Gentet, Rémy Couderc, Aurélie Chevance, Céline Mahier-Ait Oukhatar, Natacha Entz-Werle, Jean-Yves Blay, Marie-Cecile Le Deley